Covid 19 Research using Clinical Trials (Home Page)
Human milk donorsWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (2)
Correlated MeSH Terms (6)
Correlated HPO Terms (1)
|
Name (Synonyms) |
Correlation |
HP:0011947 | Respiratory tract infection HPO | 0.21 |
There is one clinical trial.
Clinical Trials
The Canadian Paediatric Society recommends breastfeeding during COVID-19 infection. Human
milk is the best form of infant nutrition providing significant protection against many
illnesses for term and preterm infants. When mothers of hospitalized infants are unable to
supply their milk, the recommended supplement is human donor milk. The impact of a pandemic
on human milk banking is unknown. This study seeks to address this public health issue. Donor
milk will be collected from the Rogers Hixon Ontario Human Milk Bank at Sinai Health System
in Toronto. Samples will be analyzed for the COVID-19 virus specific nucleic acid and
antibody in real-time and results will be immediately disseminated to relevant organizations
to inform local, national and international guidelines surrounding donor milk banking to
protect the health of infants.
NCT04453982 Sars-CoV2 Breastmilk Other: Human milk donors
Primary Outcomes
Measure: SARS-CoV-2 in breastmilk Time: 2 months
Measure: SARS-CoV-2 antibody in breastmilk Time: 2 months
No related HPO nodes (Using clinical trials)